This work highlights BMP9-mediated fibroproliferation as a critical factor in the early stages of flare-up initiation and positions BMP9 as a promising therapeutic target for managing both flare-ups and heterotopic ossification early in FOP progression. Here, GDF2 is linked to fibrodysplasia ossificans progressiva.